Literature DB >> 1984800

High risk of severe bleeding in aged patients with chronic idiopathic thrombocytopenic purpura.

S Cortelazzo1, G Finazzi, M Buelli, A Molteni, P Viero, T Barbui.   

Abstract

The purpose of this study was to estimate the incidence and to establish which factors were associated with an increased risk of hemorrhagic complications in an historic cohort of 117 consecutive and unselected patients with chronic idiopathic thrombocytopenic purpura (ITP). Sixty-eight patients (58%) underwent medical treatment and/or splenectomy and 33 (48% of treated) achieved a complete stable remission. At equivalent platelet count the incidence of major hemorrhagic complications was significantly higher in aged (greater than 60 years) than in younger (less than 40 years) patients (10.4% v 0.4%/pt-y, relative risk = 28.9, P less than .01). A previous hemorrhagic event was identified as another major risk factor for hemorrhage (relative risk = 27.5, P less than .0005), while hypertension and underlying disorders had no influence. We conclude that age more than 60 years and a previous history of bleeding are major risk factors for severe hemorrhages in adults with ITP.

Entities:  

Mesh:

Year:  1991        PMID: 1984800

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  31 in total

Review 1.  Helicobacter pylori Eradication in Patients with Immune Thrombocytopenic Purpura: A Review and the Role of Biogeography.

Authors:  Galit H Frydman; Nick Davis; Paul L Beck; James G Fox
Journal:  Helicobacter       Date:  2015-03-01       Impact factor: 5.753

2.  Risk factors for skin, mucosal, and organ bleeding in adults with primary ITP: a nationwide study in Japan.

Authors:  Takaaki Hato; Naoki Shimada; Yoshiyuki Kurata; Masataka Kuwana; Kingo Fujimura; Hirokazu Kashiwagi; Toshiro Takafuta; Mitsuru Murata; Yoshiaki Tomiyama
Journal:  Blood Adv       Date:  2020-04-28

3.  Recent advances in the treatment of chronic refractory immune thrombocytopenic purpura.

Authors:  Kiarash Kojouri; James N George
Journal:  Int J Hematol       Date:  2005-02       Impact factor: 2.490

4.  Laparoscopic splenectomy in the elderly: a morbid procedure?

Authors:  S M Kavic; R D Segan; A E Park
Journal:  Surg Endosc       Date:  2005-10-03       Impact factor: 4.584

5.  Cyclosporin A as an immunosuppressive treatment modality for patients with refractory autoimmune thrombocytopenic purpura after splenectomy failure.

Authors:  Samo Zver; Irena Preloznik Zupan; Peter Cernelc
Journal:  Int J Hematol       Date:  2006-04       Impact factor: 2.490

6.  Unusual presentation of chronic idiopathic thrombocytopenic purpura.

Authors:  M Madhusudhanan; Ali M Yusuff
Journal:  Oman Med J       Date:  2008-01

Review 7.  Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review.

Authors:  C Neunert; N Noroozi; G Norman; G R Buchanan; J Goy; I Nazi; J G Kelton; D M Arnold
Journal:  J Thromb Haemost       Date:  2015-01-14       Impact factor: 5.824

8.  Management of chronic immune thrombocytopenic purpura: targeting insufficient megakaryopoiesis as a novel therapeutic principle.

Authors:  Andreas Rank; Oliver Weigert; Helmut Ostermann
Journal:  Biologics       Date:  2010-05-25

9.  Long-term outcomes of a 5-year follow up of patients with immune thrombocytopenic purpura after splenectomy.

Authors:  Jae Joon Han; Sun Kyung Baek; Jae Jin Lee; Si-Young Kim; Kyung Sam Cho; Hwi-Joong Yoon
Journal:  Korean J Hematol       Date:  2010-09-30

Review 10.  Immune thrombocytopenia.

Authors:  Gaurav Kistangari; Keith R McCrae
Journal:  Hematol Oncol Clin North Am       Date:  2013-06       Impact factor: 3.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.